(MedPage Today) — Risk of suicidality wasn’t higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two other popular classes of diabetes drugs, a U.K. cohort study found.
In fully adjusted models, new initiators…
Source link
More Data Assuage Suicide Concerns With GLP-1 Agents
